Sign In
PROG.US
id: 1282

Progenity (PROG) Investor Settlement

S.D. California
Court
3:20-cv-01683
Case number
22 Jun 2020
Class period Start
28 Aug 2020
Class period End
Progenity has reached an agreement with $PROG investors to settle claims that its IPO statement was negligently prepared, concealing $10.3M in overbilling.
Case Status
Tentative Settlement
Alleged Offence
Mismanagement
Misleading Statements
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Filing date
27 October 2020
Plaintiffs
Lin Shen
Defendants
Harry Stylli, Eric d’Esparbes, Jeffrey Alter, John Bigalke, Jeffrey Ferrell, Brian L. Kotzin, Samuel Nussbaum, Lynne Powell
Judge
William Q. Hayes
Trades matching type
FIFO

Frequently Asked Questions

Progenity Inc

Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company develops targeted oral delivery of biotherapeutics, inclu...

    Ticker
    PROG.US
    ISIN
    US74319F1075
    CIK
    1580063
    Sector
    Healthcare
    Industry
    Biotechnology
    Country
    USA
    Address
    4330 La Jolla Village Drive, San Diego, CA, United States, 92122